Neurogene Inc.
18.69
0.80 (4.47%)
At close: Jan 15, 2025, 3:49 PM

Neurogene Statistics

Share Statistics

Neurogene has 20.98M shares outstanding. The number of shares has increased by 63.23% in one year.

Shares Outstanding 20.98M
Shares Change (YoY) n/a
Shares Change (QoQ) 61.46%
Owned by Institutions (%) n/a
Shares Floating 16.17M
Failed to Deliver (FTD) Shares 6.74K
FTD / Avg. Volume 1.69%

Short Selling Information

The latest short interest is 914.19K, so 4.36% of the outstanding shares have been sold short.

Short Interest 914.19K
Short % of Shares Out 4.36%
Short % of Float 5.65%
Short Ratio (days to cover) 7.15

Valuation Ratios

The PE ratio is -6.84 and the forward PE ratio is -8.62.

PE Ratio -6.84
Forward PE -8.62
PS Ratio 0
Forward PS 816.3
PB Ratio 1.34
P/FCF Ratio -4.8
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Neurogene Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.

Current Ratio 8.72
Quick Ratio 8.72
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage -4631.92

Financial Efficiency

Return on equity (ROE) is -0.2% and return on capital (ROIC) is -27.48%.

Return on Equity (ROE) -0.2%
Return on Assets (ROA) -0.16%
Return on Capital (ROIC) -27.48%
Revenue Per Employee 0
Profits Per Employee -399.09K
Employee Count 91
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -44.27% in the last 52 weeks. The beta is 0, so Neurogene 's price volatility has been lower than the market average.

Beta 0
52-Week Price Change -44.27%
50-Day Moving Average 29.76
200-Day Moving Average 36.53
Relative Strength Index (RSI) 31
Average Volume (20 Days) 398.04K

Income Statement

Revenue n/a
Gross Profit -3.26M
Operating Income -55.58M
Net Income -36.32M
EBITDA -52.29M
EBIT n/a
Earnings Per Share (EPS) -2.83
Full Income Statement

Balance Sheet

The company has 148.21M in cash and 16.25M in debt, giving a net cash position of 131.96M.

Cash & Cash Equivalents 148.21M
Total Debt 16.25M
Net Cash 131.96M
Retained Earnings -187.15M
Total Assets 164.12M
Working Capital 127.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.42M and capital expenditures -321.00K, giving a free cash flow of -51.74M.

Operating Cash Flow -51.42M
Capital Expenditures -321.00K
Free Cash Flow -51.74M
FCF Per Share -4.03
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NGNE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -15.72%
FCF Yield -13.71%
Dividend Details

Analyst Forecast

The average price target for NGNE is $60, which is 233.3% higher than the current price. The consensus rating is "Buy".

Price Target $60
Price Target Difference 233.3%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Stock Splits

The last stock split was on Dec 19, 2023. It was a backward split with a ratio of 1:4.

Last Split Date Dec 19, 2023
Split Type backward
Split Ratio 1:4

Scores

Altman Z-Score 8.24
Piotroski F-Score 1